Menu Close

Author: WorkCompAcademy

CWCI Elects Directors for 2018

Rose Barrett of the Berkshire Hathaway Group was elected chair of the California Workers’ Compensation Institute board of directors for 2018.

Barrett was first elected to the CWCI board as a representative of AIG in 2014 and has been a member of the institute’s executive committee since 2015, serving as vice-chair in 2017.

Also on CWCI’s 2018 executive committee will be Martin Brady of Schools Insurance Authority, an associate member; Susan Gordon, Zurich North America; David Mitchell, Republic Indemnity Company of America; Rob Shatsnider, CompWest Insurance Co.; Vernon Steiner, State Compensation Insurance Fund; and Matthew Zender, AmTrust North America.

Those elected to serve on CWCI’s 2018 board were:

– Sharon Thaler, AIG;
– Roger Moseley, Alaska National Insurance Co.;
– Paul Ziegler, Allianz Global Corporate and Specialty;
– Justin Boardman, CHUBB;
– David Macy, EMPLOYERS;
– Gretchen Thompson, The Hartford Insurance Group;
– Amanda Granger, ICW Group;
– John Dickey, Liberty Mutual Insurance;
– Kris Mathis, Pacific Compensation Insurance Company;
– Eric Hansen, Preferred Employers Group;
– Eric Belk, Travelers;
– Diana Harrelson, Zenith Insurance Co.; and
– Kevin Confetti, University of California, an associate member.

CWCI members include 24 insurer groups comprised of nearly 200 underwriting companies that write and service more than 83 percent of California statewide workers’ comp premium, as well as 32 of the largest public and private self-insured employers in the state.

L.A. Drug Treatment Center Owner Sentenced to 11 Years

The co-owner of a Los Angeles drug and alcohol treatment facility pleaded guilty to 46 felony counts related to a $175 million fraudulent health care billing scheme.

Deputy District Attorney Shaun Gipson of the Healthcare Fraud Division said that Los Angeles County Superior Court Judge Charlaine Olmedo immediately sentenced Kirsten Wallace (dob 4/3/73) to 11 years in state prison,.

Wallace entered an open plea to five counts of insurance fraud, seven counts of grand theft of personal property, six counts of identity theft and 28 counts of money laundering. The open plea means a sentence was not negotiated with the District Attorney’s Office. A restitution hearing is scheduled for April 17 in Department 105 of the Foltz Criminal Justice Center.

Wallace and Christopher Bathum (dob 9/22/61), who together owned Community Recovery of Los Angeles, were charged in the billing scheme in November 2016. The company operated treatment centers in Southern California and Colorado.

Gipson said the two defendants allegedly obtained multiple health care insurance policies for their clients by using their personal identifying information and falsified the clients’ circumstances to obtain the policies. The patients were unaware that policies had been issued in their name, the prosecutor said.

Bathum and Wallace also are accused of billing former clients after their treatment ended while those clients were still working at Community Recovery and no longer receiving treatment. Between June 2012 and December 2015, Bathum and Wallace allegedly fraudulently billed an estimated $175 million, Gipson said.

In most instances, bills were sent for services allegedly never provided. About $44 million was paid out by five insurance companies, the prosecutor said.

Bathum is charged with the same 46 counts as Wallace had faced. His next scheduled court appearance is a pretrial conference also April 17 in Department 105.

Bathum faces up to 45 years and four months in state prison if convicted as charged.

Last month in a separate case, Bathum was convicted of sexually assaulting seven women who were patients at his treatment center. A sentencing setting hearing in that case is scheduled April 17 in Department 105. The defendant faces a maximum possible sentence of about 65 years in state prison and lifetime sex offender registration.

Case BA451664 was investigated by the California Department of Insurance and the District Attorney’s Office’s Bureau of Investigation.

So. Cal. Physician to Serve 13 Years for Drug Trafficking

A San Gabriel Valley doctor who pleaded guilty to a federal drug trafficking charge for illegally distributing OxyContin was sentenced to over 13 years in federal prison.

Dr. Daniel Cham, 49, a Covina resident who formerly operated a clinic in La Puente, was sentenced by United States District Judge Andrew J. Guilford.

Acting on tip about a pharmacy that was filling a large number of prescriptions written by Cham, special agents with the Drug Enforcement Administration discovered a “large-scale criminal operation” in which Cham was writing thousands of prescriptions for powerful painkillers, often in combination with alprazolam (often sold under brand name Xanax) or carisoprodol (often sold under the brand name Soma), according to court documents. “The combination of these drugs is particularly dangerous, and is associated with the majority of overdose deaths,” according to a sentencing memorandum filed in court.

An affidavit previously filed in this case discussed how an undercover officer made three visits to Cham’s La Puente office in 2014, and how Cham wrote prescriptions for controlled substances in exchange for $200 or $300 in cash or money orders. As discussed in the court document, Cham issued a prescription for oxycodone even though the undercover operative said he “had been high and drunk while receiving controlled substance prescriptions” previously from Cham.

On another occasion, Cham prescribed oxycodone even though the undercover law enforcement officer presented, in lieu of photo identification, a written notice that his license had been suspended for driving under the influence.

Cham pleaded guilty in April 2016 to one count of distribution of oxycodone, a powerful and addictive painkiller marketed under various names, including OxyContin, Vicodin and Norco. Cham also pleaded guilty to one count of money laundering.

Prosecutors wrote in court documents that Cham “stands before the court for selling prescriptions for massive amounts of oxycodone to persons he well knew were drug dealers and addicts, in exchange for hundreds of thousands of dollars in cash. Defendant’s illegal prescriptions killed at least two addicted youths, including a 22-year-old woman and 28-year-old man.”

The young woman, who was a resident of Oregon, died after ingesting narcotics prescribed by Cham to members of Oregon-based drug trafficking conspiracy. Cham issued prescriptions in the names of the Oregon drug traffickers – many of whom he had never met – and Cham created fake paperwork to make it falsely appear he had examined the “patients.” Investigators in Oregon identified over 12,000 pills of oxycodone that Cham illegally prescribed to the drug traffickers in that state.

In a plea agreement filed in this case, Cham admitted that he unlawfully prescribed oxycodone to an undercover agent posing as a patient in March 2014 in exchange for $300 in money orders, which Cham then deposited into a bank account held in the name of another business. Cham made the deposit “knowing that the transaction was designed to conceal and disguise the nature and source of the money orders,” according to the plea agreement.

Injured Workers’ Opioid Prescriptions Decline

Opioids remain the most common type of prescription drug used to treat California injured workers with lost-time injuries, but sustained efforts to curb their use are paying off as new data show that in the past decade they fell from about a third of indemnity claim prescriptions to less than a quarter, while there was a concurrent increase in anti-inflammatories and anticonvulsants which are often used as opioid alternatives.

A new study by researchers at the California Workers’ Compensation Institute (CWCI), based on data from 12.5 million prescriptions dispensed to California injured workers from 2007 to June 2017, measures changes in the prescription and payment distributions among major therapeutic drug groups used in indemnity claims, then takes an in-depth look at the trends in the volume, cost, potency and types of opioids used.

The authors found that although opioids remained the top drug group prescribed to workers with lost-time injuries, over the span of the study their share of indemnity claim prescriptions declined from a record 32.1% in 2008 and 2009 to 23.2% in 2017, while their share of the prescription payments fell from 30.5% to 18.6%.

As in prior research, the new data show the decline in opioid use accelerated in 2012, which tracks with tighter scrutiny by utilization review and independent medical review programs; restrictions by payors, pharmacy benefit managers, and medical provider networks; and increased physician and public awareness of opioid risks.

The 2017 data show that while opioid use has dwindled, both anti-inflammatories and anticonvulsants now account for increased shares of indemnity claim prescriptions, while dermatological drugs had the biggest increase in payments, more than doubling from 6.9% of the 2008 drug spend to 16.1% of the 2017 payments, largely due to the growing prevalence of high-cost dermatological creams.

As for the opioids, the study found they have become less prevalent in the early stages lost-time claims, which bodes well for the future as historically the percentage of claims involving opioids shows little change beyond one year post injury. The study also shows that the total number of morphine equivalents (MMEs) dispensed per opioid user at different levels of claim development has declined sharply since accident year 2012, though looking at the development data on claims from each accident year show that when opioids have been used to treat chronic pain, the average strength per opioid prescription has continued to increase over time, often doubling between 3 months and 60 months post injury, underscoring the importance of weaning injured workers off of these drugs.

In addition to the prevalence, payment and potency trends, the study also examines brand vs. generic opioid drug trends, as well as changes in the prescription and payment distributions for the most common opioids, based on drug ingredient.

CWCI has published its study in a Research Update report, “California Workers’ Comp Prescription Drug Distributions & Opioid Trends.

IMR Physicians Upheld 91% of UR Treatment Denials

New data on the Independent Medical Review (IMR) process used to resolve California workers’ comp medical disputes show that IMR volume dipped for the first time ever in 2017, but the outcomes were unchanged as IMR physicians again upheld 91.2% of modified or denied medical service requests that they reviewed.

The California Workers’ Compensation Institute (CWCI) analysis is based on a review of 648,450 IMR decision letters issued from 2014 through 2017 in response to applications submitted to the state after a UR physician modified or denied a requested medical service. In adopting IMR in 2012 state lawmakers anticipated that once doctors, attorneys and others came to know which services could be approved as meeting evidence-based medicine standards the process would reduce treatment disputes, but 2017 marks the first time in the five years since its inception that IMR volume has declined, as the Division of Workers’ Compensation data show 3,808 fewer cases in 2017 than in 2016, which translates to a relatively modest 2.2% decline.

A review of the 2017 IMR results shows that IMR physicians upheld the Utilization Review (UR) doctors’ modifications or denials of requested services 91.2% of the time, which was exactly the same uphold rate as in 2014 and in 2016.

The mix of service requests reviewed by IMR physicians in 2017 showed only minor changes from 2016, as prescription drug requests (29.1% of which were for opioids) again accounted for the largest share of the IMRs (46.0% vs. 47.9% in 2016), with UR determinations on pharmaceutical requests upheld 92.0% of the time. Aside from the opioid requests, requests for musculoskeletal drugs, dermatologicals, and anti-inflammatory drugs topped the list of pharmaceutical IMRs, while compound drug requests fell from 6.5% of the prescription drug IMRs in 2016 to 4.2% in 2017, the biggest decline of any prescription drug category, which may be linked to the fact that IMR physicians have consistently deemed them not medically necessary in 99% of the cases.

Similar results were noted for most of the dermatological requests, with IMR physicians upholding modifications or denials of requests for topical local anesthetics, manufactured topicals, and topical corticosteroids 97% to 98% of the time. Among other medical service categories, physical therapy, injections, and durable medical equipment once again combined for about a quarter of the IMRs in 2017, but no other medical service category represented more than 5% of the disputed requests. Among all medical service categories, requests for evaluation and management services (primarily referrals for consultations) again had the best chance of being overturned by IMR, (an IMR uphold rate of 79.2%), while modifications or denials of physical therapy and acupuncture were the least likely to be overturned, with IMR upheld 94.0% of the time for both categories.

As in prior years, most of the disputed requests that went through IMR in 2017 came from a small number of physicians, with the top 10% of physicians who were named in decision letters (1,150 physicians) accounting for 85% of the disputed requests, while the top 1% (115 providers) accounting for 45%. Los Angeles and Bay Area continue to represent a disproportionately high share of the IMR cases relative to their share of paid medical services, while the more rural areas have a disproportionately low share of the IMR cases.

CWCI has released a more detailed analysis of the 2017 IMR results in a Research Update, “Independent Medical Review Decisions: January 2014 Through December 2017.”

Ventura Hospital Worker Sentenced in Fraud Case

A former Ventura hospital worker was ordered to pay more than $26,000 in restitution and sentenced to 60 days in jail for workers’ compensation insurance fraud.

Michelle Cordero, 50, formerly of Ventura but now living in Nocona, Texas, pleaded guilty to one felony count of insurance fraud in January, according to court records. She was also sentenced to five years of supervised probation.

Prosecutors said Cordero filed a workers’ compensation claim in July 2015 for a right shoulder injury she said happened while moving a shelf while working at Community Memorial Hospital. In her report, Cordero also denied having prior shoulder injuries and went to only one doctor.

A subsequent investigation revealed that not only had she been seeing multiple doctors, but also that she had reported that she had just injured her right shoulder while moving boxes at her residence.

Cordero, a phlebotomist, filed a second claim alleging that she had contracted meningitis from a patient at Community Memorial Hospital. Under oath, she denied she had been in contact with anyone who had meningitis.

An investigation would later reveal that her live-in boyfriend had recently been sick with meningitis and that she intentionally concealed the information from the insurer.

As part of her sentence, Cordero must pay $26,089.76 in restitution to Sedgewick Claims Management Services Inc.,

This case was the result of an investigation by the California Department oflnsurance’s Valencia Fraud Division and the District Attorney’s Workers’ Compensation Insurance Fraud Unit.

Researchers Say a Third of CT and MRI Scans Unnecessary

A new study published in the JAMA and summarized by Reuters claims the U.S. spends about twice what other high-income nations do on health care but has the lowest life expectancy and the highest infant mortality rates.

For the study, researchers examined international data from 2013 to 2016 comparing the U.S. with 10 other high-income countries: the U.K., Canada, Germany, Australia, Japan, Sweden, France, Denmark, the Netherlands, and Switzerland.

In 2016, the U.S. spent 17.8 percent of its gross domestic product (GDP) on healthcare. Other countries’ spending ranged from a low of 9.6 percent of GDP in Australia to a high of 12.4 percent of GDP in Switzerland. A large part of this was administrative costs, which accounted for 8 percent of GDP in the U.S., more than double the average of 3 percent of GDP.

At the same time, the U.S. spent an average of $1,443 per person on drugs, compared with an average of $749 per person across all of the countries in the study. U.S. spending was also higher for imaging and for many of the most common medical procedures like knee replacements, surgical cesarean births, and surgeries to repair or unclog blood vessels.

If the U.S. did less imaging and fewer of 25 common procedures, and lowered prices and the number of procedures to levels in the Netherlands, it would translate into a savings of $137 billion, Dr. Ezekiel Emanuel of the Perelman School of Medicine at the University of Pennsylvania writes in an accompanying editorial.

“Regardless of what is done with the money, it would be more valuable than paying high prices for a large number of CT and MRI scans, up to a third of which may be deemed unnecessary and carry radiation risks, and many expensive but not necessary surgical procedures,” Emanuel writes.

Life expectancy in the U.S. was the lowest, at 78.8 years, the study also found. In the other countries, life expectancy ranged from 80.7 to 83.9 years. Infant mortality rates were highest in the U.S., with 5.8 fatalities out of every 1,000 live births. For other countries, the average infant mortality rate was 3.6 fatalities for every 1,000 live births.

Employer’s Obligation to Provide Interactive Process is Continuous

Priority Business Services, a staffing agency, provides industrial staffing to hundreds of companies in a variety of industries, including distribution, light manufacturing, food service, maintenance, and clerical positions. Priority has approximately 3,500 employees placed in jobs on any given week, with a database of approximately 360,000 employees.

Rene Bolanos began work for Priority in mid-2013. He suffered an injury in January 2014 while working for one of Priority’s customers.  He was released to work with restrictions, which Priority initially accommodated by assigning him to the staffing office.

However, Bolanos asserted that in February 2014, he was diagnosed with a hernia. Priority refused to place him back in the staffing office, informed him that it could no longer accommodate him with his restrictions, and removed him from work. Bolanos further alleged that he was released to work with no restrictions, in November 2014, but Priority never gave him another job. Moreover, Priority told him in December 2014 that he would have to reapply to be returned to work. Bolanos did so in February 2015, but Priority then told him he “did not qualify to go back to work.”

Bolanos sued and asserted the following causes of action: (1) disability discrimination in violation of FEHA; (2) retaliation in violation of FEHA; (3) retaliation in violation of the California Family Rights Act (CFRA) (§ 12945.2 et seq.); (4) failure to prevent discrimination and retaliation in violation of FEHA; (5) failure to provide reasonable accommodation in violation of FEHA; (6) failure to engage in a good faith interactive process in violation of FEHA; (7) declaratory judgment; and (8) wrongful termination in violation of public policy. He sought economic damages, damages for emotional distress, and punitive damages, in total estimated to exceed $1,000,000. Bolanos separately filed a statement of damages seeking $5,000,000 in punitive damages.

The jury found in favor of Bolanos on his fifth cause of action for failure to provide reasonable accommodation and his sixth cause of action for failure to engage in an interactive process. The jury awarded Bolanos damages totaling $39,966.84, split evenly between past economic and non-economic loss. The jury found Bolanos was not entitled to punitive damages.The court granted Priority’s request to offset the judgment by $8,500, the amount paid to Bolanos in worker’s compensation benefits. The court found that Bolanos was the prevailing party and awarded attorney fees in the amount of $231,470.50.

Priority appealed, but the Court of Appeal affirmed in the unpublished case of Bolanos v. Priority Business Services.

Under FEHA it is an unlawful employment practice for an employer ‘to fail to make reasonable accommodation for the known physical or mental disability of an applicant or employee. It is the employee’s burden to initiate the process, no magic words are necessary, and the obligation arises once the employer becomes aware of the need to consider an accommodation. Once the interactive process is initiated, the employer’s obligation to engage in the process in good faith is continuous, and extends beyond the first attempt at accommodation and continues when the employee asks for a different accommodation or where the employer is aware that the initial accommodation is failing and further accommodation is needed.

Temp Agency CEO Convicted of Premium Fraud

The Stanislaus County District Attorney Birgit Fladager announced that Aileen Ramirez, age 31, of Denair, has been convicted of felony workers’ compensation insurance premium fraud.

In 2012, Ramirez was the owner and CEO of Quality Employment Services, LLC, in Modesto, a company that provided temporary workers to cover absences, skills shortages and seasonal workloads for client companies.

Ramirez obtained a workers’ compensation policy for her business from the California State Compensation Insurance Fund in February, 2012 and maintained that policy through August, 2014.

As an employer, Ramirez was required by state law to have workers’ compensation insurance for her employees and submit payroll records to the State Fund showing the number of employees and their income. This information helps the State Fund set workers’ compensation insurance premium rates for other employers throughout the state.

When State Fund performed an audit of the policy, it discovered that Ramirez had underreported her payroll and total number of employees in order to obtain a lower workers’ compensation insurance premium. In total, Ramirez underreported $2.8 million dollars in payroll that resulted in a loss to the State Fund of $525,253.58 in insurance premiums.

In April of 2016, Ramirez was charged with insurance fraud in Stanislaus County Superior Court.

On February 27, 2018, Ramirez pled no contest to violating Insurance Code §11880(a), as a felony, in that she knowingly made false and fraudulent material statements to State Fund for the purposes of determining and reducing the premium, cost or rate of her workers’ compensation insurance policy. She was immediately sentenced to 120 hours of community service, three years formal probation, and ordered to pay restitution of $525,253.58 to the State Compensation Insurance Fund.

This conviction resulted from a joint investigation by the California Department of Insurance, Fraud Division and the Amador County Workers’ Compensation Fraud Unit, which investigates and prosecutes insurance fraud cases in Amador, Stanislaus, Calaveras, and Tuolumne Counties through a grant provided by the California Department of Insurance.

WCIRB Reports on Weaning Opioid Use

The WCIRB has released its Study of Chronic Opioid Use and Weaning in California Workers’ Compensation. This Study uses data from the WCIRB databases of medical transaction records and unit statistical reports to help understand the cost implications of chronic opioid use and the process of weaning injured workers off of opioids in California workers’ compensation.

Until 2012, opioid use in California workers’ compensation, as in many other systems, was growing. Since 2012, claims with opioid prescriptions in the California workers’ compensation system have dropped sharply but opioid prescriptions still reflect a significant portion of all pharmaceutical costs.

About 22% of the claims with accidents in 2013 and 2014 with at least one paid medical service had an opioid prescription, with those claims accounting for about 60% of the total medical payments of all 2013 and 2014 claims within two years of the date of injury.

The recent decline in opioid use is attributable to both fewer newer claims for which opioids were prescribed and a reduction in opioid use on claims in which there was “chronic” opioid use. There is limited information available on workers’ compensation claimants who “weaned” off of opioids.

Approximately 60% of the chronic opioid claims involved permanent disability compared to 11% of all claims. Conversely, only 3% of the chronic opioid claims were medical only claims compared to 65% of all claims.

The median time from achieving chronic opioid status to wean off of opioids completely was 8 months. The median time from accident date to when the worker was weaned off completely was 19 months.

Claims involving chronic opioid use are considerably more expensive than the typical workers’ compensation claim. The average medical payments per claim for physician services over the 24-month period after the accident date for claims involving chronic opioid use was more than nine times the average of all claims.

During the first 6 months after weaning started, weaned claim opioid payments dropped 48% and total drug payments decreased by 42% compared to the payments during the 6 months before weaning. The percentage of payments per claim for non-opioid pain medications (i.e., NSAIDs) reduced significantly less than the decreases of both total drug payments and the opioid payments for the weaned claims during the 6 months after weaning began.

Injured workers who did not wean off of opioids were significantly more likely to have a major surgery than those who weaned off. However, injured workers who weaned off of opioids were more likely to have a major surgery within 30 days of the injury date.